Skip to main content
Clinical Trials/CTRI/2023/07/055549
CTRI/2023/07/055549
Recruiting
Phase 1

A comparative study on efficacy between ultrasound-guided botulinum toxin type a injection to salivary glands and oral glycopyrrolate therapy for management of sialorrhea in cerebral palsy - Nil

Institute of Postgraduate Medical Education and Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: G80- Cerebral palsy
Sponsor
Institute of Postgraduate Medical Education and Research
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Institute of Postgraduate Medical Education and Research

Eligibility Criteria

Inclusion Criteria

  • 1\.Confirmed case of cerebral palsy.
  • 2\.Drooling Severity (DS) Scale score 3 or more.
  • 3\.Drooling Frequency (DF) scale score 3 or more.
  • 4\.Consent from the guardian or relative

Exclusion Criteria

  • 1\.Local site infection. 2\.Allergy to botulinum toxin type A or oral Glycopyrrolate.
  • 3\.H/O severe Dysphagia.
  • 4\.H/O surgery done for controlling of sialorrhea. Or any h/o of salivary gland excision surgery mainly parotid and submandibular. 5\.Abnormal coagulation profile. 6\.Patients suffering from unstable cardio vascular or serious respiratory diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials